41+ min ago  (183+ words) The Hans India The Tripartite Agreement Signing Ceremony under the Bio NEST Co-Incubation Programme was successfully held at ICAR-NAARM, Hyderabad, marking a pivotal step in strengthening the agri-biotech ecosystem of India The agreement was signed on Thursday between a-IDEA, which…...

55+ min ago  (43+ words) Insilico Medicine Pharma. AI Spring Kickoff 2026: Drive the Future of Pharmaceutical Intelligence - MMAI Gym: Turning Foundation Models into High-Performance Drug Discovery Engines - Generative Biologics: Cyclic Peptide Design & Linear Peptide Optimization...

57+ min ago  (737+ words) 36 Kr Onc Bio Mune announced that it has cumulatively completed a $110 million Pre-IPO round of financing to accelerate the global development process of CAR-T for solid tumors. The global leader in innovative oncology immunotherapy, Oricell Therapeutics Holdings Limited (hereinafter referred…...

17+ hour, 58+ min ago  (63+ words) Emerging Growth Patterns, Segment Analysis, and Key Competitor'open PR. com Emerging Growth Patterns, Segment Analysis, and Key Competitor Approaches Influencing the Atopic Dermatitis Clinical Trials Market Press release from: The Business Research Company Permanent link to this press release: You…...

5+ hour, 24+ min ago  (14+ words) Ph RMA...

45+ min ago  (136+ words) Pharma Dispatch Cartherics and Catalent deepen partnership to accelerate next generation cell therapies Cartherics and Catalent have strengthened their collaboration to accelerate the development and future commercialisation of advanced immune cell therapies. " Sanofi's Liz Selby - 'We don't lack ideas, but…...

5+ hour, 46+ min ago  (73+ words) Trading View DCOY: AI-driven multi-antivirals advance toward clinic, targeting major respiratory virus markets AI-designed multi-antivirals are advancing toward clinical trials, targeting large unmet needs in respiratory infections with rapid, cost-effective development and broad-spectrum efficacy. Strategic partnerships and non-dilutive funding support…...

4+ hour, 28+ min ago  (896+ words) Professor Belvisi joins from Astra Zeneca, where she served as Senior Vice President, Research & Development, Respiratory & Immunology and built one of the most productive early R&D organizations in global pharma, including leading tozorakimab from preclinical research through Phase 3 investment…...

14+ hour, 35+ min ago  (227+ words) PR Newswire'Apr. 9, 2026 21: 00 Strategic Alliance: By Leveraging JW's Strengths in R&D and Commercialization in South Korea, Gan & Lee Will Establish a Strong Commercial Footprint in South Korea's High-Potential Metabolic Disease Market" Steady Progress in Global Phase III Clinical Trials; Bi-weekly…...

2+ hour, 32+ min ago  (888+ words) News-Medical Novel catalytic approach accelerates synthesis of branched drug compounds When chemists design drug candidates, shape matters enormously. Many active pharmaceutical ingredients contain branched carbon structures-points where the molecular chain forks in a specific direction-that are critical to whether a…...